Clinical Trials Directory

Trials / Conditions / Toxoplasmosis, Cerebral

Toxoplasmosis, Cerebral

10 registered clinical trials studyying Toxoplasmosis, Cerebral — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedAnalysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
NCT07044037
Centre Hospitalier de Saint-Denis—
RecruitingDexamethasone for Cerebral Toxoplasmosis
NCT04341155
Universitas PadjadjaranPhase 2
CompletedA Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients
NCT00000674
National Institute of Allergy and Infectious Diseases (NIAID)N/A
CompletedA Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients
NCT00000973
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1
CompletedA Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS
NCT00000966
PfizerPhase 1
CompletedToxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse
NCT00002064
Palo Alto Medical FoundationN/A
CompletedA Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infe
NCT00000666
National Institute of Allergy and Infectious Diseases (NIAID)N/A
CompletedPhase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the
NCT00000794
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2
CompletedA Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Hu
NCT00001994
Glaxo WellcomeN/A
CompletedPrimary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients
NCT00000643
National Institute of Allergy and Infectious Diseases (NIAID)Phase 2